Table 1

Table to illustrate the baseline characteristics between the four groups

CABGPCIP value*Revascularised
(PCI/CABG)
Medical managementP value†
Total numbers(74)(14)(88)(31)
 Age (years)69±871±80.7669±975±110.01
 Male92% (68)71% (10)0.04989% (78)77% (23)0.13
Mode of admission
 Elective51% (38)43% (6)0.5750% (44)45% (14)0.4
 Acute43% (32)29% (4)0.3941% (36)32% (10)0.43
 Emergent5% (4)29% (4)0.089% (8)23% (7)0.11
Type of lesion
 Ostial/mid shaft45% (33)21%(3)0.0941% (36)42% (13)0.54
 Distal/bifurcation55% (41)79 %(11)59% (55)58% (18)
Anatomical characteristics
 No. non-LMS vessels with sig. stenosis1.8±1.11.7±1.00.631.8±1.01.99+1.00.83
 SYNTAX24±925±80.6824±925±90.75
 Diabetes mellitus12% (9)14% (2)0.8313% (11)16% (5)0.76
 CKD16% (12)14% (2)0.8616% (14)10% (3)0.39
Risk factor profile
 HTN36% (27)29% (4)0.5235% (31)42% (13)0.52
 Smoking14% (10)0 (0%)0.1411% (10)6% (2)0.23
 Family history5% (4)0 (0%)0.375% (4)3% (1)0.75
 Lung disease4% (3)14% (2)0.136% (5)6% (2)0.88
 Ejection fraction52%±1342%±100.0150%±1348%±150.4
  • *P value for significance between coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI).

  • †P value for significance between medical management and revascularisation, that is, PCI or CABG.

  • MACE, major adverse cardiovascular event–composite between MI, TVR, stroke and all-cause mortality; MI, myocardial infarction; SYNTAX, Synergy between PCI with Taxus and Cardiac Surgery; TVR, target vessel revascularisation.